Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-28 to 2025-05-29
Current total value of award: $7347.15
Description: 4568376834!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML